Back to Search
Start Over
Risk of hepatitis B reactivation is controllable in patients with B‐cell lymphoma receiving anti‐CD19 CAR T cell therapy.
- Source :
- British Journal of Haematology; Oct2020, Vol. 191 Issue 1, p126-129, 4p
- Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 191
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 146138504
- Full Text :
- https://doi.org/10.1111/bjh.16951